The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Main David since 2017.
The trader's CIK number is 1599941.
At the time of the last reporting, Main David was the President and CEO of Neoleukin Therapeutics, Inc.. (stock ticker symbol NLTX).
Also see all insider trading activities at Neoleukin Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | AQXP | 0 | $0 | 15,625 | $207,243 | 15,625 | $150,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-05 | AQXP | Sale | 3,625 | 13.16 | 47,697 |
| 2017-06-05 | AQXP | Option Ex | 3,625 | 9.60 | 34,800 |
| 2017-06-02 | AQXP | Sale | 6,000 | 13.59 | 81,558 |
| 2017-06-01 | AQXP | Sale | 6,000 | 13.00 | 77,988 |
| 2017-06-02 | AQXP | Option Ex | 6,000 | 9.60 | 57,600 |
| 2017-06-01 | AQXP | Option Ex | 6,000 | 9.60 | 57,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Main David (President and CEO of Neoleukin Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.